Faithward Advisors, LLC

Position in ABBV — AbbVie Inc.

CIK 1695078 LANCASTER, PA

Position in ABBV

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$1,558,154

-$135,870 QoQ

Shares Held

6,192

-16.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.34%

of 13F equity value

Holder Rank

#2,146

of 4,153 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Faithward Advisors, LLC holds $6,902,856 across 7 Drug Manufacturers - General names. ABBV ranks #2 (22.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	7,824	$1,987,061
2	ABBV	AbbVie Inc. This page	6,192	$1,558,154
3	MRK	Merck & Co., Inc.	9,353	$1,201,860
4	LLY	ELI LILLY & Co	862	$1,033,908
5	AMGN	Amgen Inc	1,269	$459,530
6	GILD	Gilead Sciences, Inc.	3,229	$407,951
7	BMY	Bristol Myers Squibb Co	4,415	$254,392

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,558,154	6,192	-16.5%	Shares	Sole	2026-08-12
2025-12-31	$1,694,024	7,414	+83.2%	Shares	Sole	2026-02-17
2025-09-30	$937,042	4,047	+36.8%	Shares	Sole	2025-11-19
2025-06-30	$549,249	2,959	+13.4%	Shares	Sole	2025-08-14
2025-03-31	$546,637	2,609	-3.7%	Shares	Sole	2025-05-16
2024-12-31	$481,567	2,710	-2.3%	Shares	Sole	2025-02-13
2024-09-30	$548,007	2,775	-2.5%	Shares	Sole	2024-11-14
2024-06-30	$487,974	2,845	+2.5%	Shares	Sole	2024-08-14
2024-03-31	$505,327	2,775	+36.7%	Shares	Sole	2024-05-15
2023-06-30	$273,501	2,030	+13.2%	Shares	Sole	2023-08-15
2023-03-31	$285,749	1,793	+26.9%	Shares	Sole	2023-05-15
2022-12-31	$228,354	1,413	-56.3%	Shares	Sole	2023-02-14
2020-06-30	$317,514	3,234	-13.3%	Shares	Sole	2020-08-13
2020-03-31	$284,112	3,729	—	Shares	Sole	2020-05-12
No filing history on record for this holder in this stock.